Covid 19 Immunity
-
{
- All
- News
- Videos
- Web Stories
-
Covid Virus May Spread More Widely By Turning Lung Cells Into Targets, Study Says
A new study shows how the Covid virus may spread more widely by turning resistant lung cells into infection targets, offering clues to severe disease.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
New Cicada Covid-19 Variant BA.3.2 Detected In The US: Key Facts, Symptoms, Risk Factors Explained
A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.
-
Long Covid And Alzheimer's Might Be Driven By Similar Changes In The Brain, Says New Study
A new study from New York University finds that long Covid and Alzheimer's may share biological pathways, with choroid plexus changes linked to brain inflammation, waste clearance issues, and cognitive decline.
-
Loss Of Smell May Linger For Years After Covid-19: Study
Although it may not be noticeable, the loss of smell may linger for years for some people after a Covid-19 infection, according to a study.
-
Covid May Age Women's Blood Vessels By 5 Years: Study
A Covid-19 infection can accelerate ageing in blood vessels around five years, particularly in women, according to research.
-
"More Prepared Than Ever For Coronavirus Mutations": Scientists
A new variant of the virus that causes Covid-19 has put countries on alert as scientists scramble to understand the contagiousness and immunity to defend against it, CNN reported on Sunday.
-
Coronavirus: Everything You Need To Know About The New Covid Variant Arcturus
In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.
-
Beijing Has Hit 'Temporary Herd Immunity': China Health Official
Beijing has reached "temporary herd immunity" and its Covid outbreak is nearing an end, a city health official said Tuesday, in another sign China's unprecedented virus wave is waning.
-
Omicron BF.7 In India: All You Need To Know About Highly Infectious Sub-Variant
The BF.7 sub-variant brings concerns as it can surpass immunity from previous infections and vaccines.
-
No Evidence On Omicron's Severity In India: Centre's Research Body
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant o
-
Boris Johnson On "Best" Single Defence Against Covid Variant Omicron
Booster COVID-19 vaccines increase the body's immune response and remain the best single defence against the new Omicron variant of coronavirus, British Prime Minister Boris Johnson said on Tuesday.
-
Vaccine Efficacy Against New Covid Variant Under Examination: Scientist
Vaccines that have been directed towards the spike protein of the virus may find difficulty in mounting adequate immunity against the mutated version because of the structural changes that have been reported in the viral genome, according to WHO.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
6 Months' Immunity In Mild Covid Patients As Antibodies Persist: Study
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
-
Covid Virus May Spread More Widely By Turning Lung Cells Into Targets, Study Says
A new study shows how the Covid virus may spread more widely by turning resistant lung cells into infection targets, offering clues to severe disease.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
New Cicada Covid-19 Variant BA.3.2 Detected In The US: Key Facts, Symptoms, Risk Factors Explained
A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.
-
Long Covid And Alzheimer's Might Be Driven By Similar Changes In The Brain, Says New Study
A new study from New York University finds that long Covid and Alzheimer's may share biological pathways, with choroid plexus changes linked to brain inflammation, waste clearance issues, and cognitive decline.
-
Loss Of Smell May Linger For Years After Covid-19: Study
Although it may not be noticeable, the loss of smell may linger for years for some people after a Covid-19 infection, according to a study.
-
Covid May Age Women's Blood Vessels By 5 Years: Study
A Covid-19 infection can accelerate ageing in blood vessels around five years, particularly in women, according to research.
-
"More Prepared Than Ever For Coronavirus Mutations": Scientists
A new variant of the virus that causes Covid-19 has put countries on alert as scientists scramble to understand the contagiousness and immunity to defend against it, CNN reported on Sunday.
-
Coronavirus: Everything You Need To Know About The New Covid Variant Arcturus
In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.
-
Beijing Has Hit 'Temporary Herd Immunity': China Health Official
Beijing has reached "temporary herd immunity" and its Covid outbreak is nearing an end, a city health official said Tuesday, in another sign China's unprecedented virus wave is waning.
-
Omicron BF.7 In India: All You Need To Know About Highly Infectious Sub-Variant
The BF.7 sub-variant brings concerns as it can surpass immunity from previous infections and vaccines.
-
No Evidence On Omicron's Severity In India: Centre's Research Body
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant o
-
Boris Johnson On "Best" Single Defence Against Covid Variant Omicron
Booster COVID-19 vaccines increase the body's immune response and remain the best single defence against the new Omicron variant of coronavirus, British Prime Minister Boris Johnson said on Tuesday.
-
Vaccine Efficacy Against New Covid Variant Under Examination: Scientist
Vaccines that have been directed towards the spike protein of the virus may find difficulty in mounting adequate immunity against the mutated version because of the structural changes that have been reported in the viral genome, according to WHO.
-
As UK Rollouts Jabs For Children, A Study To Test Mixed Dose Schedules
A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.
-
6 Months' Immunity In Mild Covid Patients As Antibodies Persist: Study
A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
